# Residual Cardiovascular Risk Despite Optimal LDL Cholesterol Reduction with Statins: The Evidence, Etiology, and Therapeutic Challenges

Review · Uchechukwu K.A. Sampson, Sergio Fazio, MacRae F. Linton

- Archive id: doi:10.1007/s11883-011-0219-7
- Published: 2011-11-18
- Venue: Current Atherosclerosis Reports
- DOI: https://doi.org/10.1007/s11883-011-0219-7
- PMID: 22102062
- Citations: 439
- Source URL: https://doi.org/10.1007/s11883-011-0219-7
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [Cardiovascular Therapeutics](https://space-kitty.com/topics/cardiovascular-innovation)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.